Company Filing History:
1 out of 9 
1 out of 2 
1 out of 6 Years Active: 2013-2016
Title: Innovations in Cardiovascular Risk Assessment: The Contributions of Scott V Monte
Introduction
Scott V Monte, an accomplished inventor based in West Seneca, NY, has made significant contributions to the field of personalized medicine through his innovative patents. With three patents to his name, Monte's work particularly focuses on assessing cardiovascular risks in patients with Metabolic Syndrome and Type 2 Diabetes. His groundbreaking methods aim to improve therapeutic interventions and optimize pharmaceutical compositions tailored to individual patient needs.
Latest Patents
Among Scott V Monte's notable inventions is a method and system designed to provide personalized pharmaceutical compositions and dosages. This innovative approach involves a comprehensive assessment of cardiovascular risk in patients suffering from Metabolic Syndrome and Type 2 Diabetes. By obtaining relevant data from these patients, Monte's method determines a Fayad/Schentag index, which includes a unique Glucose Supply Index (S) to Insulin Demand Index (D) ratio. This index is instrumental in scoring cardiovascular risks and guiding healthcare professionals in implementing effective therapeutic interventions aimed at lowering such risks.
Career Highlights
Throughout his career, Scott V Monte has been associated with several prominent companies in the medical technology and pharmaceutical sectors, including Therasyn Sensors, Inc. and Therabrake, Inc. His roles at these organizations have allowed him to further develop his knowledge and skills within the fields of medicine and innovation.
Collaborations
Monte has collaborated with notable experts in the field, including Jerome J Schentag and Joseph M Fayad. These partnerships have enriched his research and have been crucial in the development of his patented methodologies, thereby enhancing the effectiveness of risk assessments and therapeutic approaches in cardiovascular health.
Conclusion
Scott V Monte stands as a prominent figure in the realm of medical innovation, particularly in assessing and managing cardiovascular risks associated with Metabolic Syndrome and Type 2 Diabetes. His patents not only reflect his dedication to advancing personalized medicine but also signify the potential for improved patient outcomes through tailored healthcare solutions. As the field continues to evolve, Monte's contributions remain vital for both researchers and patients alike.